Harmony Biosciences Holdings, Inc. announced that Kumar Budur, MD, MS, was appointed Chief Medical Officer in May 2023. Dr. Budur most recently served as Senior Vice President and Head of Clinical Development for Harmony.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.95 USD | +2.04% | +3.17% | -7.28% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.28% | 1.7B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences Holdings, Inc. Appoints Kumar Budur as Chief Medical Officer